mayurakkhi.bhatia@Biochemical Pharmacology Presentation_10.03.24 Mayurakkhi Bhatia
mayurakkhi.bhatia@Biochemical Pharmacology Presentation_10.03.24 Mayurakkhi Bhatia
mayurakkhi.bhatia@Biochemical Pharmacology Presentation_10.03.24 Mayurakkhi Bhatia
Cell Excitation
Mayurakkhi Bhatia
College of Pharmacy
Long Island University
• Channels are controlled by intracellular
ligands.
• Cyclic Nucleoside-Gated (CNG) channels.
• Inward rectifier potassium (Kir ) channels.
• Transient Receptor Potential (TRP)
Contents channels.
• Voltage-gated channels of nerve cells as
drug targets.
• Sodium channel blockers in local
anesthesia.
• Voltage-gated channels and epilepsy.
• Ligand-gated channels can be
classified based on where the ligand
binding site is located.
• Extracellular-Outside the cell
Channels • Intracellular-Within the cell
Controlled • Extracellularly binding ligands
by includes neurotransmitters ( ex.
Ionotropic receptors).
Intracellular • Intracellular ligands maybe
Ligands secondary messengers that relay
extracellular signals (ex. Calcium
play a role in calcium activated
potassium channels).
Cyclic
Nucleoside-
Gated (CNG)
Channels
It includes 4 subunits that each
contain 6 transmembrane helices.
Each subunit contains one cyclic
nucleotide binding site.
Binding of cAMP or cGMP opens
the channel for Na+, K+, Ca2+
Reference : Wong, Ching-On and Xiaoqiang Yao. “Cyclic nucleotide-gated channels: a familiar channel family with a new function?” Future
cardiology 4 5 (2008): 505-15 .
• Cyclic nucleotide-gated (CNG) channels are ion
channels which are activated by the binding of
and Epilepsy
Pharmacological modulation of ion channels is widely
used in these cases, as well as in other forms of
epilepsy.
Voltage-Gated Channels and
Epilepsy
NaV inhibitors used in the treatment of epilepsy are phenytoin and carbamazepine
Unlike local anesthetics, they only cause slow channel block, in which they delay channel
reactivation.
While the activity of most nerve cells depends on upstream input, some groups of nerve cells in the
brain generate intrinsic, spontaneous activity. This occurs in a manner like that of the pacemaker cells
in the heart and involves two different types of CaV channels, the T-type and the L-type channels.
Mutations in T-type channel genes can cause a specific form of epilepsy known as generalized
absences. This condition is treated with ethosuximide, which inhibits T-type channels.
In contrast to NaV and CaV channels, KV channels mediate membrane hyperpolarization, so that drugs
that promote the open state of these channels will reduce excitability.
This therapeutic approach has only recently been put into practice. The drug retigabine promotes
opening of KCNQ or type 7 KV channels, which occur in the CNS and is currently in clinical trials.
References
TEXTBOOK OF BIOCHEMICAL
PHARMACOLOGY
-–M PALMER ( 2012 EDITION )
Thank You